These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9894330)

  • 1. [Final bedside verification: results of a national survey of reagents and devices used in France].
    Noizat-Pirenne F; Le Pennec PY; Lascaux JM; Fraval D; Zaoui F; Rouger P
    Transfus Clin Biol; 1998 Dec; 5(6):392-6. PubMed ID: 9894330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diversity of bedside pretransfusion ABO compatibility devices in metropolitan France].
    Migeot V; Tellier S; Ingrand P
    Transfus Clin Biol; 2003 Feb; 10(1):26-36. PubMed ID: 12668185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Technical methods for the ultimate verification at the patient's bedside].
    Le Pennec PY; Rouger P
    Rev Fr Transfus Hemobiol; 1991 Mar; 34(2):167-71. PubMed ID: 2031656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of ABO discrepancies occurring in 35 French hospitals.
    Chiaroni J; Legrand D; Dettori I; Ferrera V
    Transfusion; 2004 Jun; 44(6):860-4. PubMed ID: 15157252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunologic risk analysis of blood transfusion: 1991-1998].
    Rouger P; Le Pennec PY; Noizat-Pirenne F
    Transfus Clin Biol; 2000 Feb; 7(1):9-14. PubMed ID: 10730341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of the removal of A2 test erythrocytes and the anti-AB reactant on the interpretation of the ABO blood grouping].
    Chiaroni J
    Transfus Clin Biol; 2001 Aug; 8(4):381-9. PubMed ID: 11642030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quality control of reactant lots at the Nation Blood Group Reference Center (CNRGS). Data for the year 1998].
    Noizat-Pirenne F; Le Pennec PY; Rouger P
    Transfus Clin Biol; 1999 Jun; 6(3):195-200. PubMed ID: 10422213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Accidental transfusion with ABO-incompatible blood: process for analysis of the contributing causes].
    Indrikovs AJ
    Sangre (Barc); 1997 Jun; 42(3):205-13. PubMed ID: 9381263
    [No Abstract]   [Full Text] [Related]  

  • 9. [Yes, we should keep ABO agglutination test within bedside transfusion checks].
    Daurat G
    Transfus Clin Biol; 2008 Nov; 15(5):322-6. PubMed ID: 18930425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The pretransfusion bedside agglutination test is not a "Gold Standard"].
    Levy G
    Transfus Clin Biol; 2008 Nov; 15(5):318-21. PubMed ID: 18930684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consecutive national surveys of ABO-incompatible blood transfusion in Japan.
    Fujii Y; Shibata Y; Miyata S; Inaba S; Asai T; Hoshi Y; Takamatsu J; Takahashi K; Ohto H; Juji T; Sagawa K
    Vox Sang; 2009 Oct; 97(3):240-6. PubMed ID: 19476605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Errors in interpreting the pretransfusion bedside compatibility test: an experimental study.
    Dujardin PP; Salmi LR; Ingrand P
    Vox Sang; 2000; 78(1):37-43. PubMed ID: 10729810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of the computer cross-match.
    Engelfreit CP; Reesink HW; Krusius T; Wendel S; Fontäo-Wendel R; Hoffer I; Medgyesi G; Tadokoro K; Pisacka M; Kühnl P; Schwartz DW; Mayr WR; Schönitzer D; Lin CK; James V; Castel A; Hazenberg CA; Letowska M; Solheim BG; Guerts M; Ghosh S; Flanagan P; Epstein J; Säfwenberg J; Riccardi D; Sirchia G
    Vox Sang; 2001 Apr; 80(3):184-92. PubMed ID: 11449959
    [No Abstract]   [Full Text] [Related]  

  • 14. ABO rechecking should be performed in the same institution as computer crossmatch.
    Brooks JP; Fletcher CH
    Transfusion; 2013 Feb; 53(2):465-6. PubMed ID: 23384104
    [No Abstract]   [Full Text] [Related]  

  • 15. North American pretransfusion testing practices, 2001-2004: results from the College of American Pathologists Interlaboratory Comparison Program survey data, 2001-2004.
    Shulman IA; Maffei LM; Downes KA
    Arch Pathol Lab Med; 2005 Aug; 129(8):984-9. PubMed ID: 16048410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in transfusion safety using a specially designed transfusion wristband.
    Lau FY; Wong R; Chui CH; Ng E; Cheng G
    Transfus Med; 2000 Jun; 10(2):121-4. PubMed ID: 10849382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of the pretransfusion bedside compatibility test: association with transfusion practice and training.
    Ingrand P; Surer-Pierres N; Houssay D; Salmi LR
    Transfusion; 1998; 38(11-12):1030-6. PubMed ID: 9838933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three low-ionic-strength solutions for routine pretransfusion testing: antibody screening/identification, cross-matching, immune anti-ABO detection, and direct antiglobulin tests.
    Kaspi E; Mallié F; Gouvitsos J; Dettori I; Chiaroni J; Ferrera V
    Transfusion; 2009 Dec; 49(12):2772-3. PubMed ID: 20163691
    [No Abstract]   [Full Text] [Related]  

  • 19. Automated point-of-care testing for ABO agglutination test: proof of concept and validation.
    El Kenz H; Corazza F
    Vox Sang; 2015 Jul; 109(1):79-85. PubMed ID: 25766458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current state of transfusion practices for ABO-incompatible pediatric heart transplant patients in the United States and Canada.
    Dean CL; Sullivan HC; Stowell SR; Fasano RM; West LJ; Robitaille N; Josephson CD
    Transfusion; 2018 Sep; 58(9):2243-2249. PubMed ID: 30145826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.